Table 3.
Comparison among economic parameters of two strategies for control of severe asthma (n = 64)
| year before ProAR (US Dollars) | year after ProAR (US Dollars) | ||
| median (quartile) | median (quartile) | p* | |
| Government annual costs of treatment per patient | |||
| Cost of outpatient treatment | 184 (177/192) | 359 (240/471) | < 0.01 |
| Cost of hospital treatment | 590 (78/1330) | 0 (0/19) | < 0.01 |
| Total annual government costs of treatment | 750 (286/1462) | 363 (255/481) | < 0.01 |
| Family annual costs of treatment and income | |||
| Family income | 2768 (1912/4033) | 3280 (2191/5050) | 0.02 |
| Family expenses with asthma (direct cost) | 615 (343/1374) | 74 (34/275) | < 0.01 |
| Proportion of income spent with asthma | 29% | 2% | |
| Losses for patient and companion (indirect cost) | 0 (0/134) | 0 (0/0) | < 0.01 |
| Total family costs (direct + indirect) | 807 (358/1509) | 74 (35/281) | < 0.01 |
* Wilcoxon Signed Rank Tests